Follow RSS for latest reports on this topicRecombinant DNA - Market Research and Reports

Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology.

The procedure is to cut the DNA of the donor organism into pieces with restriction enzymes, and insert one of these fragments into the DNA of the host. Most of the time a bacterial or virus plasmid is used to insert the donor DNA. A plasmid is a circular DNA fragment, which can be opened with the same restriction enzymes as the DNA fragment of the donor. A plasmid containing DNA from the donor is called a vector. The recombinant vector can then be used to transform bacterial or virus cells. These bacterial cells are plated and colonies are grown.

Key development stages:

  • cutting and pasting pieces of DNA from different genomes using enzymes.
  • techniques used to transfer foreign DNA into new host cells
  • identification of promoters to express foreign DNA

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...



or can supply a pro-forma invoice if required.

Related Reports:

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023 [Report Updated: 14-08-2018]

“Global vaccines market projected to grow at a CAGR of 6.7%”The vaccines market is expected to reach USD 50.42 billion by 2023 from USD 36.45 billion in 2018, at a CAGR of 6.7%. Rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, and increasing company initiatives to enhance R&D are driving the growth of the vaccines market. On the other hand...Read More >>>

Published:
2018-08-14

Published by: MarketsandMarkets

Prices Starting From:
$5650

Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, rHGH, Interferon), Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing Type (In-house, Contract), Disease (Oncology, Autoimmune) - Global Forecast to 2023 [Report Updated: 06-04-2018]

“The global biosimilars market projected to grow at a CAGR of 31.7% during the forecast period.”The biosimilars market is expected to reach USD 23.63 billion by 2023 from USD 5.95 billion in 2018, at a CAGR of 31.7%. Factors driving the growth of this market include increasing demand for biosimilar drugs due to their cost-effectiveness, rising incidence of chronic diseases, and strategic colla...Read More >>>

Published:
2018-04-06

Published by: MarketsandMarkets

Prices Starting From:
$5650

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021) [Report Updated: 14-09-2016]

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, growing prevalence of chronic diseases among aging population are the prime growth drivers of global remicade biosimilar market. In addition, increase in adoption of remicade biosimilar in emerging ...Read More >>>

Published:
2016-09-14

Published by: Industry ARC

Prices Starting From:
$5250

Biosimilars Market: By Product (Recombinant Glycosated Proteins and Others) Technology (mAbs, Chromatography, Mass Spectroscopy and Others); By Application (Blood & Oncology Diseases, Chronic Diseases and Others); By Geography-Forecast (2016 - 2021) [Report Updated: 11-07-2016]

Biosimilars are subsequent entry biologics (SEB) which are introduced into the market as the original biologic approaches patent expiry. Unlike the biologics, biosimilars are expressed in living cells which brings variability in the properties of the biosimilars. Hence, they possess properties similar to the biologic instead of being an exact copy of the original drug.Biosimilars are emerging as o...Read More >>>

Published:
2016-07-11

Published by: Industry ARC

Prices Starting From:
$5250

Published:
2015-07-16

Published by: MarketsandMarkets

Prices Starting From:
$5650

Additional Searches

You may also like to search separately for: Recombinant DNA

We Stock...

{STICKYFOOTERMOBILE}